Delivery Order SPE2DR25D3019-SPE2DR26FK4EC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,756.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with completion required by November 26, 2025. This firm fixed-price delivery order, issued on November 25, 2025, represents a non-competitive award under DLA's broader pharmaceutical procurement strategy and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.76 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,811.84 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on December 12, 2025, with completion scheduled for December 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The contract represents a discrete fulfillment under AmerisourceBergen's larger relationship with the...
- The Defense Logistics Agency (DLA) awarded a $10,536.80 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,683.69 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,183.77 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors, with a completion date of November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,741.93 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. The contract utilizes firm fixed-price pricing and is scheduled for completion by December 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors in 0.5 mL units. This firm fixed-price delivery order, valued at $2,867.98, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through competitive...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4ECDelivery Order
The Defense Logistics Agency (DLA) awarded a $17,669.62 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors (0.5 ml units), with a completion date of December 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's comprehensive contract portfolio includes a wide range of pharmaceutical products spanning multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Mounjaro, a GLP-1 receptor agonist diabetes medication, demonstrates the contractor's continued role in supplying specialty pharmaceuticals to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 12/15/25 |